The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis

Myung-Yong Lee
Myung-Yong Lee
Sola Han
Sola Han
Mi-Mi Won
Mi-Mi Won
Yoo-Jung Park
Yoo-Jung Park
Ji-Min Lee
Ji-Min Lee
Hee-Youn Choi
Hee-Youn Choi
Seongsik Kang
Seongsik Kang

PloS one, 2020.

Cited by: 0|Bibtex|Views0|DOI:https://doi.org/10.1371/journal.pone.0242922
WOS
Other Links: pubmed.ncbi.nlm.nih.gov|academic.microsoft.com

Abstract:

Among Asian patients who were associated with higher bleeding risk, low adherence, and receiving reduced NOAC dose than that provided in randomised controlled trials, all NOACs were associated with a significantly lower S/SE risk and apixaban and dabigatran with a significantly lower MB risk than warfarin.

Code:

Data:

Your rating :
0

 

Tags
Comments